Concepedia

Ying Shu

YS

Statistics

Publications

4

Citations

167

H-Index

4

Active since

2018

Affiliations

Anhui Provincial Hospital(Current)

University of Science and Technology of China

Hefei National Center for Physical Sciences at Nanoscale

Chinese Academy of Sciences

Ying Shu is an author at Anhui Provincial Hospital specializing in oncology, molecular oncology, and medicine.

Publications per year

2018–2022

4

Publications

4

DIS3L2 Promotes Progression of Hepatocellular Carcinoma via hnRNP U-Mediated Alternative Splicing

Songge Xing, Zhaoyong Li, Wenhao Ma et al. · Cancer Research · 2019 · 49 citations · Full text

Medicine, Cancer Biology, Oncology +17

Genome-wide CRISPR screen identifies synthetic lethality between DOCK1 inhibition and metformin in liver cancer

Junru Feng, Hui Lü, Wenhao Ma et al. · Protein & Cell · 2022 · 48 citations · Full text

Medicine, Oncology, Pharmacology +17

Non‐canonical phosphoglycerate dehydrogenase activity promotes liver cancer growth via mitochondrial translation and respiratory metabolism

Ying Shu, Yijie Hao, Junru Feng et al. · The EMBO Journal · 2022 · 37 citations · Full text

Life Sciences, Molecular Biology, Oncology +15

Targeted resequencing reveals genetic risks in patients with sporadic idiopathic pulmonary fibrosis

Yanhan Deng, Zongzhe Li, Juan Liu et al. · Human Mutation · 2018 · 33 citations

Life Sciences, Genetics, Molecular Genetics +17

1–4 of 4